Biogen Inc. revenue for the last year amounted to 9.68 B USD, the most of which — 9.62 B USD — came from its highest performing source at the moment, Innovative Therapies, the year earlier bringing 9.84 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Biogen Inc. 5.31 B USD, and the year before that — 5.43 B USD.